Comparison of epirubicin and vinorelbine with cyclophosphamide, epirubicin, and fluorouracil as neoadjuvant chemotherapy for operable breast cancer

被引：0
|
作者：
Han, S. [1 ]
Kwak, K. [1 ]
Kim, J. [1 ]
Kim, J. [1 ]
Park, K. [1 ]
机构：
[1] Inje Univ, Sanggye Paik Hosp, Breast Canc Ctr, Seoul, South Korea
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Epirubicin (E) followed by cyclophosphamide, methotrexate, 5-fluorouracil (CMF) versus paclitaxel (T) followed by epirubicin and vinorelbine (EV) in patients (pts) with high-risk operable breast cancer
    Boccardo, F.
    Rubagotti, A.
    Guglielmini, P.
    Sismondi, P.
    Farris, A.
    Amadori, D.
    Agostara, B.
    Gambi, A.
    Catalano, G.
    Faedi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: Results of a randomized trial
    Coombes, RC
    Bliss, JM
    Wils, J
    Morvan, F
    Espie, M
    Amadori, D
    Gambrosier, P
    Richards, M
    Aapro, M
    VillarGrimalt, A
    McArdle, C
    PerezLopez, FR
    Vassilopoulos, P
    Ferreira, EP
    Chilvers, CED
    Coombes, G
    Woods, EM
    Marty, M
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 35 - 45
  • [23] Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel plus epirubicin and cyclophosphamide
    Andersen, Kenneth Geving
    Jensen, Maj-Britt
    Kehlet, Henrik
    Gartner, Rune
    Eckhoff, Lise
    Kroman, Niels
    ACTA ONCOLOGICA, 2012, 51 (08) : 1036 - 1044
  • [24] Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients
    Wang, Zhi
    Dang, Chengxue
    Zhu, Kun
    Zhang, Yong
    Chang, Dongmin
    Xia, Peng
    Song, Yongchun
    Li, Kang
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) : 1088 - 1092
  • [25] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Kimura, Morihiko
    Tominaga, Takeshi
    Takatsuka, Yuichi
    Toi, Masakazu
    Abe, Rikiya
    Koyama, Hiroki
    Takashima, Shigemitsu
    Nomura, Yasuo
    Miura, Shigeto
    Kimijima, Izo
    Tashiro, Hideya
    Ohashi, Yasuo
    BREAST CANCER, 2010, 17 (03) : 190 - 198
  • [26] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Morihiko Kimura
    Takeshi Tominaga
    Yuichi Takatsuka
    Masakazu Toi
    Rikiya Abe
    Hiroki Koyama
    Shigemitsu Takashima
    Yasuo Nomura
    Shigeto Miura
    Izo Kimijima
    Hideya Tashiro
    Yasuo Ohashi
    Breast Cancer, 2010, 17 : 190 - 198
  • [27] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Wang, Xinguang
    He, Yingjian
    Wang, Tianfeng
    Xie, Yuntao
    Li, Jinfeng
    Ouyang, Tao
    Fan, Zhaoqing
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 3019 - 3025
  • [28] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Xinguang Wang
    Yingjian He
    Tianfeng Wang
    Yuntao Xie
    Jinfeng Li
    Tao Ouyang
    Zhaoqing Fan
    Supportive Care in Cancer, 2019, 27 : 3019 - 3025
  • [29] Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
    Poole, Christopher J.
    Earl, Helena M.
    Hiller, Louise
    Dunn, Janet A.
    Bathers, Sarah
    Grieve, Robert J.
    Spooner, David A.
    Agrawal, Rajiv K.
    Fernando, Indrajit N.
    Brunt, A. Murray
    O'Reilly, Susan M.
    Crawford, S. Michael
    Rea, Daniel W.
    Simmonds, Peter
    Mansi, Janine L.
    Stanley, Andrew
    Harvey, Peter
    McAdam, Karen
    Foster, Liz
    Leonard, Robert C. F.
    Twelves, Christopher J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (18): : 1851 - 1862
  • [30] A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer
    E. Esteban
    González de Sande
    J. Puertas
    J. Fra
    I. Palacio
    J.M. Vieitez
    J.L. Fernández
    I. Muñiz
    A. Modollel
    J. Carrasco
    M. Sala
    A.J. Lacave
    Breast Cancer Research and Treatment, 2000, 62 : 127 - 133
12345